Ocean Biomedical Stock Today

OCEAW Stock   0.04  0  9.77%   

Performance

4 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Over 85

 
High
 
Low
Very High
Ocean Biomedical is selling for under 0.036 as of the 30th of November 2024; that is 9.77% down since the beginning of the trading day. The stock's lowest day price was 0.0349. Ocean Biomedical has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Ocean Biomedical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 11th of December 2022 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
5th of November 2021
Category
Healthcare
Classification
Health Care
Ocean Biomedical is entity of United States. It is traded as Stock on NASDAQ exchange. More on Ocean Biomedical

Moving against Ocean Stock

  0.35INAB In8bio IncPairCorr

Ocean Stock Highlights

Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities31.5 M30 M
Sufficiently Up
Slightly volatile
Ocean Biomedical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ocean Biomedical's financial leverage. It provides some insight into what part of Ocean Biomedical's total assets is financed by creditors.
Liquidity
Ocean Biomedical has accumulated 12.12 M in total debt. Note, when we think about Ocean Biomedical's use of debt, we should always consider it together with its cash and equity.

Change In Cash

1.02 Million
Ocean Biomedical (OCEAW) is traded on NASDAQ Exchange in USA. It is located in null and employs 9 people. Ocean Biomedical is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry. Ocean Biomedical generates negative cash flow from operations
Check Ocean Biomedical Probability Of Bankruptcy

Ocean Biomedical Historical Income Statement

At this time, Ocean Biomedical's Depreciation And Amortization is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 10.4 M in 2024, whereas Operating Income is likely to drop (10.7 M) in 2024. View More Fundamentals

Ocean Stock Against Markets

Additional Tools for Ocean Stock Analysis

When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.